Nancy R. Cook

Q: What Schools Are Affiliated With Nancy R. Cook

Nancy R. Cook is affiliated with the following schools: University of California, Berkeley, Stanford University, Johns Hopkins University, Harvard University

Nancy R. Cook's AcademicInfluence.com Rankings

Nancy R. Cook

Computer Science

#3103

World Rank

#3253

Historical Rank

Machine Learning

#296

World Rank

#300

Historical Rank

Artificial Intelligence

#471

World Rank

#480

Historical Rank

Database

#605

World Rank

#635

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Nancy R. Cook's Degrees

PhD Computer Science Stanford University
Masters Computer Science University of California, Berkeley
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Nancy R. Cook Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nancy R. Cook's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures (2010) (3297)
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women (2003) (2421)
Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. (1989) (1992)
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women (2005) (1947)
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction (2007) (1916)
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. (2007) (1720)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. (2002) (1571)
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) (2007) (1196)
Physical Activity and Reduced Risk of Cardiovascular Events: Potential Mediating Mechanisms (2007) (961)
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease (2019) (933)
Long-Term Weight Loss and Changes in Blood Pressure: Results of the Trials of Hypertension Prevention, Phase II (2001) (891)
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. (2005) (861)
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. (2016) (847)
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men (2008) (839)
Implications of small reductions in diastolic blood pressure for primary prevention. (1995) (784)
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. (2005) (769)
Low-Dose Aspirin in the Primary Prevention of Cancer: The Women’s Health Study: A Randomized Controlled Trial (2005) (746)
The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. (1992) (722)
Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. (2008) (635)
Decision Making in Advanced Heart Failure: A Scientific Statement From the American Heart Association (2012) (623)
Marine n‐3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer (2019) (572)
The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women (2006) (529)
Body mass index and the risk of stroke in men. (2002) (507)
Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores (2004) (502)
Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. (2008) (495)
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events (2003) (490)
The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. (2012) (485)
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures (2009) (484)
Statins: new American guidelines for prevention of cardiovascular disease (2013) (466)
A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. (2007) (464)
Physical Activity and Coronary Heart Disease in Women: Is No Pain, No Gain Passé? (2001) (435)
β-Carotene Supplementation and Incidence of Cancer and Cardiovascular Disease: the Women's Health Study. (1999) (428)
Relationship of physical activity vs body mass index with type 2 diabetes in women. (2004) (417)
Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. (2009) (409)
The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women's health study). (2010) (391)
Weight status in childhood as a predictor of becoming overweight or hypertensive in early adulthood. (2005) (371)
Association between a literature-based genetic risk score and cardiovascular events in women. (2010) (371)
Migraine and risk of cardiovascular disease in women. (2006) (364)
Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. (2008) (346)
Determination of blood pressure percentiles in normal-weight children: some methodological issues. (2008) (337)
Alcohol Consumption and the Risk of Hypertension in Women and Men (2008) (325)
Relation of vigorous exercise to risk of atrial fibrillation. (2009) (323)
Intakes of calcium and vitamin D and breast cancer risk in women. (2006) (281)
Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. (2016) (281)
Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. (2005) (280)
Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial (2013) (279)
Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3 (2009) (275)
Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. (2009) (271)
Estimates of benefits and harms of prophylactic use of aspirin in the general population (2014) (270)
Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. (1993) (269)
Prospective Study of Body Mass Index and Risk of Stroke in Apparently Healthy Women (2005) (264)
Physical activity and coronary heart disease in women: is "no pain, no gain" passé? (2001) (260)
Pharmacogenetic Study of Statin Therapy and Cholesterol Reduction (2004) (251)
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials (2018) (250)
Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health Initiative (2012) (247)
Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women (2003) (246)
Correlates of cognitive function in an elderly community population. (1988) (236)
Migraine and risk of cardiovascular disease in men. (2007) (235)
Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events (2005) (233)
A prospective study of fruit and vegetable intake and the risk of type 2 diabetes in women. (2004) (230)
Height and Incidence of Cardiovascular Disease in Male Physicians (1993) (229)
Does weight loss from middle age to old age explain the inverse weight mortality relation in old age? (1995) (228)
Childhood Blood Pressure Trends and Risk Factors for High Blood Pressure: The NHANES Experience 1988–2008 (2013) (226)
A randomized trial of vitamin E supplementation and cognitive function in women. (2006) (223)
Lower Levels of Sodium Intake and Reduced Cardiovascular Risk (2013) (223)
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women (2007) (221)
C-Reactive Protein Is Independently Associated With Fasting Insulin in Nondiabetic Women (2003) (216)
Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease (2017) (208)
A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. (2007) (203)
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. (2021) (200)
Tests of calibration and goodness‐of‐fit in the survival setting (2015) (200)
Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein. (2008) (200)
Moderate alcohol consumption and the risk of sudden cardiac death among US male physicians. (1999) (199)
Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. (2008) (197)
Alcohol consumption and risk of incident atrial fibrillation in women. (2008) (193)
Alcohol consumption and breast cancer risk in the Women's Health Study. (2006) (189)
Blood pressure measurement in childhood epidemiological studies. (1995) (184)
Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. (2008) (183)
A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. (2007) (183)
On the Use of Variance per Genotype as a Tool to Identify Quantitative Trait Interaction Effects: A Report from the Women's Genome Health Study (2010) (183)
Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts (2018) (181)
Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. (1998) (179)
Change in pulmonary function in children associated with air pollution episodes. (1982) (163)
Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. (2016) (163)
Dietary glycemic load and risk of colorectal cancer in the Women's Health Study. (2004) (162)
Smoking and Risk of Hemorrhagic Stroke in Women (2003) (161)
Dietary fat and fatty acids and risk of colorectal cancer in women. (2004) (161)
Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study. (2014) (161)
Screening for Sudden Cardiac Death in the Young: Report From a National Heart, Lung, and Blood Institute Working Group (2011) (154)
Vitamin E and Risk of Type 2 Diabetes in the Women’s Health Study Randomized Controlled Trial (2006) (151)
Tree and spline based association analysis of gene–gene interaction models for ischemic stroke (2004) (149)
Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial. (2009) (148)
Circulating Levels of Endothelial Adhesion Molecules and Risk of Diabetes in an Ethnically Diverse Cohort of Women (2007) (144)
Occupational exposures in insecticide application, and some pesticides (2004) (143)
Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. (2005) (143)
The joint effects of physical activity and body mass index on coronary heart disease risk in women. (2008) (142)
Relationship of alcohol intake with blood pressure in young adults. (1995) (142)
Genetic Loci Associated With Plasma Concentration of Low-Density Lipoprotein Cholesterol, High-Density Lipoprotein Cholesterol, Triglycerides, Apolipoprotein A1, and Apolipoprotein B Among 6382 White Women in Genome-Wide Analysis With Replication (2008) (141)
Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States) (2000) (140)
Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease: the SMART risk score (2013) (139)
Type 2 Diabetes Mellitus and Cognitive Decline in Two Large Cohorts of Community‐Dwelling Older Adults (2008) (139)
β‐carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma (1999) (139)
A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. (2010) (138)
Peak expiratory flow rate and 5-year mortality in an elderly population. (1991) (137)
Mediterranean Diet and Cognitive Function in Older Age (2013) (136)
Metabolic Predictors of Incident Coronary Heart Disease in Women (2018) (135)
C-Reactive Protein Levels Are Not Associated with Increased Risk for Colorectal Cancer in Women (2005) (133)
Estimating treatment effects for individual patients based on the results of randomised clinical trials (2011) (132)
Vitamin E, Vitamin C, Beta Carotene, and Cognitive Function Among Women With or at Risk of Cardiovascular Disease: The Women’s Antioxidant and Cardiovascular Study (2009) (131)
Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk (2008) (129)
Using relative utility curves to evaluate risk prediction (2009) (125)
Risk of Malignant Cancer Among Women With New-Onset Atrial Fibrillation. (2016) (125)
Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States) (2005) (124)
Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008. (2013) (124)
Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. (2006) (121)
Novel genetic markers improve measures of atrial fibrillation risk prediction (2013) (118)
Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women With and Without Diabetes Mellitus: The Women's Health Study (2011) (118)
Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. (2009) (116)
A trial of B vitamins and cognitive function among women at high risk of cardiovascular disease. (2008) (114)
Alanine for Proline Substitution in the Peroxisome Proliferator–Activated Receptor Gamma-2 (PPARG2) Gene and the Risk of Incident Myocardial Infarction (2003) (113)
Body Mass Index and Risk of Colorectal Cancer in Women (United States) (2004) (113)
Dietary fat types and 4‐year cognitive change in community‐dwelling older women (2012) (111)
Estrogen–progestin replacement therapy and breast cancer risk: the Women's Health Study (United States) (2002) (109)
Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease (2016) (106)
Performance of reclassification statistics in comparing risk prediction models (2011) (105)
Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women. (2006) (104)
Dietary magnesium intake and risk of cardiovascular disease among women. (2005) (104)
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial (2022) (103)
Low dose aspirin and cognitive function in the women's health study cognitive cohort (2007) (103)
Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929) (2008) (102)
Plasma homocysteine and cysteine and risk of breast cancer in women. (2010) (102)
Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. (1997) (102)
Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis. (2003) (99)
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease. (2020) (98)
Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10-year follow-up study. (2006) (96)
C-reactive protein and risk of breast cancer. (2007) (95)
Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group. (1993) (95)
Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. (2002) (94)
Peak expiratory flow rate in an elderly population. (1989) (94)
Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II (2005) (94)
A two-stage hierarchical regression model for meta-analysis of epidemiologic nonlinear dose-response data (2009) (94)
Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. (2007) (93)
Long-Term Multivitamin Supplementation and Cognitive Function in Men (2013) (92)
Lifestyle‐Based Prediction Model for the Prevention of CVD: The Healthy Heart Score (2014) (92)
Interrelationships of peak expiratory flow rate with physical and cognitive function in the elderly: MacArthur Foundation studies of aging. (1995) (91)
Vigorous-intensity leisure-time physical activity and risk of major chronic disease in men. (2012) (90)
Blood Pressure Differences by Ethnic Group Among United States Children and Adolescents (2009) (88)
Identifying children at high risk for the development of essential hypertension. (1993) (88)
A Common Variant at 9p21 Is Associated With Sudden and Arrhythmic Cardiac Death (2009) (86)
Dietary Glycemic Load and Breast Cancer Risk in the Women’s Health Study (2004) (86)
Correlates of headache in a population-based cohort of elderly. (1989) (86)
Migraine and Coronary Heart Disease in Women and Men (2002) (84)
Prediction of young adult blood pressure from childhood blood pressure, height, and weight. (1997) (84)
Endogenous sex hormones, blood pressure change, and risk of hypertension in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. (2012) (83)
Physical activity and breast cancer risk: the Women's Health Study (United States) (2001) (83)
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis (2016) (83)
A Meta-Analysis of Candidate Gene Polymorphisms and Ischemic Stroke in 6 Study Populations: Association of Lymphotoxin-Alpha in Nonhypertensive Patients (2009) (82)
Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL). (2016) (81)
Common Variants in Cardiac Ion Channel Genes Are Associated With Sudden Cardiac Death (2010) (81)
Intakes of calcium and vitamin D and risk of colorectal cancer in women. (2005) (79)
Quantifying the added value of new biomarkers: how and how not (2018) (79)
The Relation of Education and Income to Cognitive Function among Professional Women (2006) (78)
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies (2018) (78)
Effect of Homocysteine-Lowering Treatment With Folic Acid and B Vitamins on Risk of Type 2 Diabetes in Women (2009) (78)
Assessment of dietary sodium intake using a food frequency questionnaire and 24‐hour urinary sodium excretion: a systematic literature review (2017) (78)
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies (2018) (78)
Amino-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein as Predictors of Sudden Cardiac Death Among Women (2009) (76)
A prospective study of incident comprehensive medical home care use among the elderly. (1988) (76)
Hypertensive Disorders of Pregnancy and 10-Year Cardiovascular Risk Prediction. (2018) (76)
Vigorous physical activity, mediating biomarkers, and risk of myocardial infarction. (2011) (75)
BIRTH WEIGHT IS A SIGNIFICANT RISK FACTOR FOR INCIDENT ATRIAL FIBRILLATION: 1A.07 (2010) (74)
Past physical activity, current physical activity, and risk of coronary heart disease. (2005) (74)
Effect of Vitamin D3 Supplements on Development of Advanced Cancer (2020) (74)
Postmenopausal hormone therapy and migraine headache. (2003) (71)
Extrapyramidal signs and other neurologic findings in clinically diagnosed Alzheimer's disease. A community-based study. (1993) (70)
Adult height and incidence of cancer in male physicians (United States) (1997) (70)
High-Sensitivity C-Reactive Protein and Cognitive Function in Older Women (2006) (69)
Study on the effect of megavitamin E supplementation in man. (1978) (69)
Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. (2020) (69)
Strength Training and the Risk of Type 2 Diabetes and Cardiovascular Disease (2017) (69)
Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence: Prospective Data From the Women’s Health Study (2018) (69)
Estimates of benefits and harms of prophylactic use of aspirin in the general population. (2015) (68)
Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. (2018) (67)
Lipoprotein(a) and Cardiovascular Risk Prediction Among Women. (2018) (64)
Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I. (1998) (64)
C-reactive protein in the prediction of rheumatoid arthritis in women. (2006) (63)
Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. (2006) (63)
24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk. (2021) (61)
Mortality Benefits From US Population-wide Reduction in Sodium Consumption: Projections From 3 Modeling Approaches (2013) (61)
Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer. The Women’s Health Study: A Randomized Controlled Trial (2005) (61)
Using the area under the curve to reduce measurement error in predicting young adult blood pressure from childhood measures (2004) (60)
Height, lung function, and mortality from cardiovascular disease among the elderly. (1994) (59)
Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation. (2017) (58)
Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study (2009) (58)
Vitamin E in the primary prevention of rheumatoid arthritis: the Women's Health Study. (2008) (58)
An autosomal genome scan for loci influencing longitudinal burden of body mass index from childhood to young adulthood in white sibships: The Bogalusa Heart Study (2004) (58)
The fat-mass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. (2010) (57)
Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. (1995) (57)
Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. (2006) (56)
Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study. (2007) (56)
Multi‐locus candidate gene polymorphisms and risk of myocardial infarction: a population‐based, prospective genetic analysis (2006) (55)
Formulas to Estimate Dietary Sodium Intake From Spot Urine Alter Sodium-Mortality Relationship. (2019) (54)
Mammographic screening and risk factors for breast cancer. (2009) (54)
Reproducibility and predictive values of routine blood pressure measurements in children. Comparison with adult values and implications for screening children for elevated blood pressure. (1987) (53)
The Women's Antioxidant Cardiovascular Study: design and baseline characteristics of participants. (2004) (52)
Response to mortality benefits from U.S. population-wide reduction in sodium consumption: projections from 3 modeling approaches. (2013) (52)
Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies (2013) (52)
Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease. (2010) (51)
Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health Initiative (2018) (50)
Physical activity, adiposity, and risk of endometrial cancer (2009) (48)
Threonine for alanine substitution in the eotaxin (CCL11) gene and the risk of incident myocardial infarction. (2004) (48)
High-Molecular-Weight and Total Adiponectin Levels and Incident Symptomatic Peripheral Artery Disease in Women: A Prospective Investigation (2011) (48)
The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. (1995) (48)
Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State. (2015) (48)
Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent. (2011) (48)
Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA‐3 TriaL (VITAL) (2020) (47)
Comparison of Self-Reported and Accelerometer-Assessed Physical Activity in Older Women (2015) (47)
Twenty‐Four–Hour Diet recall and Diet records compared with 24‐hour urinary excretion to predict an individual’s sodium consumption: A Systematic Review (2018) (46)
Effect of long-term supplementation with folic acid and B vitamins on risk of depression in older women (2015) (46)
Prediction of incident hypertension risk in women with currently normal blood pressure. (2009) (46)
The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study. (2010) (45)
A Randomized Trial of Low-Dose Aspirin in the Prevention of Clinical Type 2 Diabetes in Women (2009) (44)
Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9 p 21 . 3 (2008) (44)
Serum Sortilin Associates With Aortic Calcification and Cardiovascular Risk in Men (2017) (43)
Blood Pressure and Risk of Secondary Cardiovascular Events in Women: The Women’s Antioxidant Cardiovascular Study (WACS) (2004) (43)
Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial. (2021) (43)
Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women (2014) (43)
How to translate clinical trial results into gain in healthy life expectancy for individual patients (2016) (42)
Clinically relevant measures of fit? A note of caution. (2012) (42)
Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program. (2005) (42)
VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population (2020) (40)
Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. (2011) (40)
Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction (2018) (40)
Assessing the Incremental Role of Novel and Emerging Risk Factors (2010) (39)
Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the Physician’s Health Study (2005) (39)
Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women's Health Study. (2017) (38)
Effectiveness and cost-effectiveness of blood pressure screening in adolescents in the United States. (2011) (38)
A Bias-Corrected Net Reclassification Improvement for Clinical Subgroups (2011) (38)
A comparison of elderly participants in a community survey with nonparticipants. (1990) (37)
VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL). (2015) (37)
Sodium and health—concordance and controversy (2020) (36)
Salt intake, blood pressure and clinical outcomes (2008) (35)
Effect of combined folic acid, vitamin B(6), and vitamin B(12) on colorectal adenoma. (2012) (35)
Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years. (2005) (35)
Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence (2020) (35)
Systematic review with meta‐analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention (2017) (34)
Haplotype Analysis of the β2 Adrenergic Receptor Gene and Risk of Myocardial Infarction in Humans (2005) (34)
Reclassification Calculations for Persons With Incomplete Follow-up (2010) (34)
Cook Prediction Use and Misuse of the Receiver Operating Characteristic Curve in Risk (2007) (34)
Dose–response of sodium excretion and blood pressure change among overweight, nonhypertensive adults in a 3-year dietary intervention study (2005) (34)
High-Dose Statin Therapy in Patients With Stable Coronary Artery Disease: Treating the Right Patients Based on Individualized Prediction of Treatment Effect (2013) (34)
A trial of omega-3 fatty acids for prevention of hypertension. (2004) (33)
Use of oral conjugated estrogen alone and risk of breast cancer. (2006) (33)
Are we ready to recommend aspirin for cancer prevention? (2012) (32)
Patterns of deficits in brain function in bipolar disorder and schizophrenia: A cluster analytic study (2012) (32)
Clinical utility of lipoprotein-associated phospholipase A₂ for cardiovascular disease prediction in a multiethnic cohort of women. (2012) (31)
Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. (2022) (31)
The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression. (2018) (30)
Methods for evaluating novel biomarkers – a new paradigm (2010) (30)
Total Magnesium Intake and Colorectal Cancer Incidence in Women (2006) (30)
Polymorphism in the &bgr;2-Adrenergic Receptor and Lipoprotein Lipase Genes as Risk Determinants for Idiopathic Venous Thromboembolism: A Multilocus, Population-Based, Prospective Genetic Analysis (2006) (30)
Physical activity, genes for physical fitness, and risk of coronary heart disease. (2013) (29)
Combining annual blood pressure measurements in childhood to improve prediction of young adult blood pressure. (2000) (29)
Calibration and seasonal adjustment for matched case–control studies of vitamin D and cancer (2016) (28)
B-type natriuretic peptides improve cardiovascular disease risk prediction in a cohort of women. (2014) (27)
Relation of renal function to risk for incident atrial fibrillation in women. (2012) (27)
Comparison of 24‐hour urine and 24‐hour diet recall for estimating dietary sodium intake in populations: A systematic review and meta‐analysis (2019) (27)
Racial Variation in Total Knee Replacement in a Diverse Nationwide Clinical Trial (2017) (27)
Biomarkers for prediction of cardiovascular events. (2007) (26)
A proposal to incorporate trial data into a hybrid ACC/AHA algorithm for the allocation of statin therapy in primary prevention. (2015) (26)
Epidemiology of leptospirosis in dairy farm workers in the Manawatu. Part I: A cross-sectional serological survey and associated occupational factors. (1980) (26)
Association of Race and Ethnicity With Late-Life Depression Severity, Symptom Burden, and Care. (2020) (26)
Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women. (2011) (26)
Multiancestral Analysis of Inflammation-Related Genetic Variants and C-Reactive Protein in the Population Architecture Using Genomics and Epidemiology Study (2014) (26)
An imputation method for non-ignorable missing data in studies of blood pressure. (1997) (26)
Simple electrocardiographic measures improve sudden arrhythmic death prediction in coronary disease. (2020) (26)
Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women. (2011) (26)
Supplementation with Vitamin D and/or Omega-3 Fatty Acids and Incidence of Heart Failure Hospitalization: VITAL-Heart Failure. (2019) (26)
Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women. (2013) (25)
Comments on ‘Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers’ by M. J. Pencina, R. B. D'Agostino, Sr. and E. W. Steyerberg (2012) (25)
No Effect of β-Carotene Supplementation on Risk of Nonmelanoma Skin Cancer among Men with Low Baseline Plasma β-Carotene (2004) (24)
Effect of Combined Treatment With Folic Acid, Vitamin B6, and Vitamin B12 on Plasma Biomarkers of Inflammation and Endothelial Dysfunction in Women (2018) (24)
Hemoglobin A1c Concentrations and Risk of Colorectal Cancer in Women (2005) (24)
A common variant in the β2-adrenergic receptor and risk of sudden cardiac death. (2011) (24)
Self-selected posttrial aspirin use and subsequent cardiovascular disease and mortality in the physicians' health study. (2000) (24)
Prospective cohort study of breast implants and the risk of connective-tissue diseases. (2011) (23)
Determining decision limits for new biomarkers: clinical and statistical considerations. (2011) (23)
Childhood blood pressure tracking correlations corrected for within-person variability. (1992) (23)
Response to Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation. (2014) (22)
Cardiovascular disease risk prediction in women: is there a role for novel biomarkers? (2014) (22)
Comparing Cardiovascular Risk Prediction Scores (2015) (22)
The Pooled Cohort Equations 3 Years On: Building a Stronger Foundation. (2016) (22)
An unexpected result for sodium--causal or casual? (1995) (21)
Impact of Subclinical Hypothyroidism on Cardiometabolic Biomarkers in Women (2017) (20)
C‐reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype‐based analysis (2004) (20)
Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in Women (2010) (20)
Regression analysis of changes in blood pressure with oral contraceptive use. (1985) (20)
Effect of Long-Term Marine -3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis (2021) (19)
Sodium and Health: Old Myths and a Controversy Based on Denial (2022) (19)
Adiposity throughout adulthood and risk of sudden cardiac death in women. (2015) (19)
Oral postmenopausal hormone therapy, C-reactive protein, and cardiovascular outcomes (2011) (19)
Lifestyle and behavioral factors and mitochondrial DNA copy number in a diverse cohort of mid-life and older adults (2020) (19)
Effects of One Year of Vitamin D and Marine Omega-3 Fatty Acid Supplementation on Biomarkers of Systemic Inflammation in Older US Adults. (2019) (19)
COMT and Alpha-Tocopherol Effects in Cancer Prevention: Gene-Supplement Interactions in Two Randomized Clinical Trials. (2019) (18)
Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. (2021) (18)
Feasibility and Efficacy of Sodium Reduction in the Trials of Hypertension Prevention, Phase I (2005) (18)
Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women (2010) (18)
Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment. (2019) (17)
Should we reconsider the role of age in treatment allocation for primary prevention of cardiovascular disease? (2016) (17)
Comparison of Lifestyle-Based and Traditional Cardiovascular Disease Prediction in a Multiethnic Cohort of Nonsmoking Women (2014) (17)
Recommended standards for assessing blood pressure in human research where blood pressure or hypertension is a major focus (2017) (17)
Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort of U.S. Women (2018) (17)
Physical activity and coronary heart disease in women. Is “no pain, no gain” passé? (2001) (17)
Statin-Associated Muscle Symptoms in the VITamin D and OmegA-3 TriaL (VITAL). (2022) (17)
Imputation strategies for blood pressure data nonignorably missing due to medication use (2006) (17)
Abstract 4992: Cardiovascular Disease Risk Prediction with and without Knowledge of Genetic Variation at Chromosome 9p21.3: The Women's Genome Health Study (2008) (17)
Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging. (2019) (16)
Restricted Maximum Likelihood (2005) (16)
Assessment of Placebo Response in Objective and Subjective Outcome Measures in Rheumatoid Arthritis Clinical Trials (2020) (16)
Marine n-3 fatty acids and prevention of cardiovascular disease and cancer (2019) (16)
Hemoglobin A1c levels and risk of sudden cardiac death: A nested case-control study. (2017) (16)
The Long- and Short-Term Impact of Elevated Body Mass Index on the Risk of New Atrial Fibrillation (2010) (15)
Aspirin in the primary prevention of cardiovascular disease in the Women’s Health Study: Effect of noncompliance (2012) (15)
Net reclassification improvement: a link between statistics and clinical practice (2013) (15)
Estimating Myocardial Infarction Size With a Simple Electrocardiographic Marker Score (2020) (15)
Effect of Vitamin D and ω-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial. (2020) (15)
Refining the American guidelines for prevention of cardiovascular disease – Authors' reply (2014) (15)
Comparison of Cardiovascular Risk Factors for Coronary Heart Disease and Stroke Type in Women (2018) (15)
Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U‐statistics (2017) (15)
Physical Activity and Incident Cardiovascular Disease in Women: Is the Relation Modified by Level of Global Cardiovascular Risk? (2018) (14)
Prospective study of plasma homocysteine, its dietary determinants, and risk of age-related macular degeneration in men (2018) (14)
Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial (2021) (14)
Physical Activity and Coronary Heart Disease in Women (2017) (14)
Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study). (2015) (14)
Association Between 9 p 21 Genomic Markers and Heart Disease : A Meta-analysis (2010) (13)
Seafood types and age-related cognitive decline in the Women's Health Study. (2013) (13)
Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular Disease (2013) (13)
Habitual Fish Consumption, n‐3 Fatty Acids, and Nuclear Magnetic Resonance Lipoprotein Subfractions in Women (2020) (13)
No effect of beta-carotene supplementation on risk of nonmelanoma skin cancer among men with low baseline plasma beta-carotene. (2004) (13)
Telomere length and its relationships with lifestyle and behavioural factors: variations by sex and race/ethnicity. (2020) (13)
Author Correction: Arrhythmic sudden death survival prediction using deep learning analysis of scarring in the heart (2022) (13)
Plasma adiponectin and the risk of hypertension in white and black postmenopausal women. (2012) (13)
Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL): Effects on Bone Structure and Architecture. (2018) (12)
Assessing the Validity of Childhood Blood Pressure Screening: Unbiased Estimates of Sensitivity, Specificity, and Predictive Values (1992) (12)
Effect of Homocysteine-lowering Treatment with Folic Acid and B Vitamins on Risk of Type 2 Diabetes Mellitus in Women : A Randomized Controlled Trial Running title : B vitamin supplementation and diabetes in women (2009) (12)
Prospective Study of Plasma Homocysteine Level and Risk of Age-Related Macular Degeneration in Women (2015) (12)
Screening rules for determining blood pressure status in clinical trials. Application to the trials of hypertension prevention. (1993) (11)
Weight change and mortality: Long‐term results from the trials of hypertension prevention (2018) (11)
Association Between a 20‐Year Cardiovascular Disease Risk Score Based on Modifiable Lifestyles and Total and Cause‐Specific Mortality Among US Men and Women (2018) (11)
Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL. (2020) (11)
C-reactive protein and coronary heart disease. (2004) (10)
Impact of Modifiable Risk Factors on B-type Natriuretic Peptide and Cardiac Troponin T Concentrations. (2016) (10)
Effects of vitamins C and E and b-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized (2009) (10)
Effect of Combined Folic Acid, Vitamin B 6 , and Vitamin B 12 on Cancer Risk in Women (2013) (10)
Comparison of Conventional TNM and Novel TNMB Staging Systems for Non–Small Cell Lung Cancer (2019) (10)
Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women (2021) (10)
The Effects of Vitamin D and Marine Omega‐3 Fatty Acid Supplementation on Chronic Knee Pain in Older US Adults: Results From a Randomized Trial (2020) (10)
Low‐dose aspirin in the primary prevention of rheumatoid arthritis: The women's health study (2010) (10)
Markers of Myocardial Stress, Myocardial Injury, and Subclinical Inflammation and the Risk of Sudden Death (2020) (10)
Prediction of Lifetime and 10-Year Risk of Cancer in Individual Patients With Established Cardiovascular Disease (2020) (9)
Statistical methods for building better biomarkers of chronic kidney disease (2019) (9)
Comment: Measures to Summarize and Compare the Predictive Capacity of Markers (2010) (9)
Diabetes Mellitus, Race, and Effects of Omega-3 Fatty Acids on Incidence of Heart Failure Hospitalization. (2022) (9)
Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL) (2021) (8)
Proceedings from the workshop on estimating the contributions of sodium reduction to preventable death (2011) (8)
Randomized Trial of the Effects of Insulin and Metformin on Myocardial Injury and Stress in Diabetes Mellitus: A Post Hoc Exploratory Analysis (2017) (8)
Historical Controls in Randomized Clinical Trials: Opportunities and Challenges (2020) (8)
Prospectively collected lifestyle and health information as risk factors for white matter hyperintensity volume in stroke patients (2019) (8)
Lack of Association Between Genetic Variation in 9 Innate Immunity Genes and Baseline CRP Levels (2006) (8)
Clinical risk reclassification at 10 years (2017) (8)
Sodium and cardiovascular disease. (2014) (7)
Prospective Evaluation of the Alcohol Dehydrogenase &ggr;1/&ggr;2 Gene Polymorphism and Risk of Stroke (2004) (7)
Adding tests to risk based guidelines: evaluating improvements in prediction for an intermediate risk group (2016) (7)
Use of aspirin as primary prevention of cardiovascular events. (2006) (7)
Estimating predictive values for blood pressure measurements from multivariate regression models with covariates. (1996) (7)
Cholesterol Evaluation in Young Adults: Absence of Clinical Trial Evidence Is Not a Reason to Delay Screening (2017) (6)
Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial. (2022) (6)
TP53 haplotype-based analysis and incidence of post-angioplasty restenosis (2004) (6)
Relation of Alanine Aminotransferase Levels to Cardiovascular Events and Statin Efficacy. (2016) (6)
Unreported financial disclosures in a study of migraine and cardiovascular disease. (2006) (5)
Reclassification calibration test for censored survival data: performance and comparison to goodness-of-fit criteria (2018) (5)
Polygenic Risk Score Predicts Sudden Death in Patients With Coronary Disease and Preserved Systolic Function. (2022) (5)
Public policy and dietary sodium restriction. (2010) (5)
Random-effects meta-analysis of inconsistent effects. (2014) (4)
Racial Variation in Stroke Risk Among Women by Stroke Risk Factors (2019) (4)
Effect of Vitamin D and/or Marine n-3 Fatty Acid Supplementation on Changes in Migraine Frequency and Severity: A randomized placebo-controlled trial. (2021) (4)
Association of Physical Activity With Bioactive Lipids and Cardiovascular Events (2022) (4)
Prospective evaluation of the alcohol dehydrogenase gamma1/gamma2 gene polymorphism and risk of stroke. (2004) (4)
Genetics and breast cancer risk prediction--are we there yet? (2010) (4)
Homocysteine, B Vitamins, MTHFR Genotype, and Incident Age-related Macular Degeneration. (2017) (4)
Practice of Epidemiology Determination of Blood Pressure Percentiles in Normal-Weight Children: Some Methodological Issues (2008) (4)
The Aromatase Gene (CYP19A1) Variants and Circulating Hepatocyte Growth Factor in Postmenopausal Women (2011) (4)
Effect of Vitamin D Supplementation on Urinary Incontinence in Older Women: Ancillary Findings from a Randomized Trial. (2021) (4)
Marine n-3 Fatty Acids and Vitamin D Supplementation and Primary Prevention. Reply. (2019) (4)
Assessing predictive performance beyond the Framingham risk score. (2010) (3)
Response to letter regarding article, "lower levels of sodium intake and reduced cardiovascular risk". (2014) (3)
307-S: Magnesium Intake, C-Reactive Protein, and the Prevalence of Metabolic Syndrome in Middle-Aged and Older us Women (2005) (3)
A Common Variant in the Beta-2 Adrenergic Receptor and Risk of Sudden Cardiac Death (2011) (3)
Response to Hypertension and children: should we be aware? (2013) (3)
Polymorphism in the 2-Adrenergic Receptor and Lipoprotein Lipase Genes as Risk Determinants for Idiopathic Venous Thromboembolism (2006) (3)
Effect of vitamin D and/or omega‐3 fatty acid supplementation on stroke outcomes: A randomized trial (2020) (3)
Marine n‐3 fatty acids and cognitive change among older adults in the VITAL randomized trial (2021) (3)
Re.: "Association of small artery elasticity with incident cardiovascular disease in older adults: the Multi-ethnic Study of Atherosclerosis". (2012) (3)
Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo. (2022) (3)
Restricted Maximum Likelihood: Introduction† (2014) (3)
Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty (2022) (3)
Evidence-Based Policy Making for Public Health Interventions in Cardiovascular Diseases: Formally Assessing the Feasibility of Clinical Trials. (2020) (3)
Abstract 5005: Development and Testing of a Risk Prediction Algorithm for Incident Hypertension in Women with Currently Normal Blood Pressure (2008) (2)
An optimal rule for screening subjects for clinical trials in the presence of within-person variability. (1994) (2)
Plasma Placental Growth Factor Concentrations Are Elevated Well in Advance of Type 2 Diabetes Mellitus Onset: Prospective Data From the WHS (2019) (2)
Vitamin D and cancer: can we believe the evidence from observational studies? (2013) (2)
Three‐Way Analyses (2011) (2)
Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts (2023) (2)
Regarding REGARDS: Does inflammation explain racial and regional differences in cardiovascular disease risk? (2009) (2)
Vitamin D supplements and marine omega-3 fatty acids and development of advanced cancer. (2020) (2)
TP53 haplotype-based analysis and incidence of post-angioplasty restenosis (2004) (2)
Validation of electrocardiographic criteria for identifying left ventricular dysfunction in patients with previous myocardial infarction (2020) (2)
AHA Scientific Statement Decision Making in Advanced Heart Failure (2012) (2)
Urinary sodium excretion and cardiovascular disease mortality. (2011) (2)
Prediction model with metabolic syndrome to predict recurrent vascular events in patients with clinically manifest vascular diseases (2012) (2)
Heart Association Decision Making in Advanced Heart Failure : A Scientific Statement From the American Print (2012) (2)
Diabetes and Risk of Sudden Death in Coronary Artery Disease Patients Without Severe Systolic Dysfunction. (2021) (2)
Screening rules for determining blood pressure status in clinical trials: Application to the trials of hypertension prevention (1992) (2)
Salt, Blood Pressure, and Cointervention-Reply (1997) (2)
The case for C-reactive protein as a risk marker for coronary heart disease. (2010) (2)
Low-dose aspirin and breast cancer risk: Results from a randomized trial (2007) (2)
Prospectively Collected Cardiovascular Biomarkers and White Matter Hyperintensity Volume in Ischemic Stroke Patients. (2020) (2)
Sex Differences in Atrial Fibrillation Risk: The VITAL Rhythm Study. (2022) (2)
Association of Body Weight With Response to Vitamin D Supplementation and Metabolism (2023) (2)
High normal weight status in childhood as a predictor of being overweight or hypertensive in early adulthood (2003) (2)
Arrhythmic sudden death survival prediction using deep learning analysis of scarring in the heart (2022) (1)
Salt: How much less should we eat for health?: Understanding the recent IOM report (2013) (1)
Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis. (2023) (1)
COMT Effects on Vitamin E and Colorectal Cancer, in-vitro and in Two Randomized Trials (P15-005-19). (2019) (1)
Evaluation and Validation: A Look at the Program Effectiveness Panel. (1991) (1)
Breast Implants and Connective-Tissue Disease-Reply (1996) (1)
Migraine and heart rate variability. Authors' reply (2007) (1)
Abstract 2184: Prospective Evaluation of a Comprehensive Genetic Risk Score for Future Cardiovascular Events Among 19,313 Initially Healthy Women: The Women's Genome Health Study (2009) (1)
Pharmacogenetic study of statin therapy and cholesterol reduction. (2004) (1)
Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial (2022) (1)
Abstract 20653: Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort of Women: The Women’s Health Initiative (2017) (1)
Migraine and Heart Rate Variability—Reply (2007) (1)
Comparison of Lifestyle Based to Traditional CVD Prediction in a Multiethnic Cohort of Non-Smoking Women (2014) (1)
Vitamin D and Omega-3 Fatty Acid Trial 2017: Addressing Effects on Muscle and Bone (2018) (1)
Effect of Combined Folic Acid, Vitamin B6, and Vitamin B12 on Risk of Colorectal Adenoma in Women: Results from a Randomized Controlled Trial (2011) (1)
Null Results in Brief Hemoglobin A 1 c Concentrations and Risk of Colorectal Cancer in Women (2005) (1)
Abstract 13479: Association of Plasma Branched Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in Women (2020) (1)
Marine n‐3 fatty acids and cognitive change among older adults in the VITAL randomized trial (1)
Prediction of 10-year and lifetime risk of cancer in individual patients with established cardiovascular disease, results from UCC-SMART and CANTOS (2020) (1)
A new community for those involved and interested in diagnosis and prognosis (2017) (1)
Weak research on dietary sodium should not generate strong conclusions on a major public health policy (2023) (1)
Haplotype Analysis of the Beta-2 Adrenergic Receptor Gene and Risk of Myocardial Infarction (2004) (1)
Abstract 3160: Inflammation and Risk of Incident Atrial Fibrillation in Women (2008) (1)
GENETIC RISK, ADHERENCE TO A HEALTHY LIFESTYLE, AND RISK OF CORONARY ARTERY DISEASE (2017) (1)
Abstract 019: Modifiable Lifestyle Factors And Plasma Branched Chain Amino Acids: An Analysis Of N=19,472 US Women (2021) (1)
Electrocardiographic Deep Learning for Predicting Post-Procedural Mortality (2022) (1)
Abstract 6207: Derivation of a Novel Prediction Algorithm for Idiopathic Venous Thromboembolism in Women (2008) (0)
Abstract 4501: Energetic risk and prostate cancer-specific and all-cause mortality in two large cohorts of men with localized prostate cancer (2012) (0)
Abstract 16387: The Contribution of Novel Genetic Markers to Atrial Fibrillation Risk Prediction Models (2010) (0)
Association of modifiable lifestyle factors with plasma branched chain amino acid metabolites in women. (2022) (0)
Re: "problems with risk reclassification methods for evaluating prediction models". (2011) (0)
Prospective Genetic Analysis Population-Based , Determinants for Idiopathic Venous Thromboembolism : A Multilocus ,-Adrenergic Receptor and Lipoprotein Lipase Genes as Risk 2 β Polymorphism in the Print (2006) (0)
Abstract 4023: Do Known Risk Factors Explain the Inverse Relation Between Physical Activity and Cardiovascular Disease Risk? (2006) (0)
LEISURE-TIME PHYSICAL ACTIVITY ASSOCIATES FAVORABLY WITH THE BIOACTIVE LIPIDOME AND RISK OF INCIDENT CVD EVENTS/ RESULTS FROM THE VITAMIN D AND OMEGA-3 TRIAL (VITAL) AND JUPITER TRIALS (2021) (0)
Abstract 9724: Impaired Renal Function is Associated with an Increased Risk for Incident Atrial Fibrillation (2011) (0)
Confidence Intervals and Sets (2005) (0)
Algorithms for assessing cardiovascular risk in women. Authors' reply (2007) (0)
Patients Based on Individualized Prediction of Treatment Effect High-Dose Statin Therapy in Patients with Stable Coronary Artery Disease: Treating the Right (2013) (0)
Abstract 10030: Validation of Framingham and Reynolds Cardiovascular Risk Prediction Models in the Women's Health Initiative (2011) (0)
Abstract 15888: N-3 Polyunsaturated Fatty Acids in Erythrocyte Membranes and Risk of Sudden Cardiac Death in Primary and Secondary Prevention (2015) (0)
Abstract 16968: A Randomized Trial of the Effects of Insulin and Metformin on Myocardial Stress in Patients With Type II Diabetes Mellitus (2017) (0)
Abstract P330: Effect of Randomized Omega-3 Treatment on Downstream Bioactive Lipids and Their Association With Incident Cardiovascular Disease Events: Metabolomic Studies of the Vital and Jupiter Trials (2023) (0)
Abstract WP247: Racial Disparities in Stroke Risk Among Older Adults in the Southern Community Cohort Study (2019) (0)
Baseline characteristics ( mean ± SD or % ) among invasive breast cancer cases and their matched controls in the Women ' s Health Study (2010) (0)
ASSOCIATION BETWEEN SERUM CALCIUM AND COGNITIVE FUNCTION IN HEALTHY PEOPLE AGED 60 OR OLDER IN THE VITAL STUDY (2016) (0)
Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein share how this access benefits you. Your story matters (2008) (0)
O1-05-02: A randomized trial of vitamins C, E and beta carotene and cognitive function among women with cardiovascular disease or risk factors (2008) (0)
Biomarkers for prediction of cardiovascular events. (2007) (0)
Algorithms for Assessing Cardiovascular Risk in Women—Reply (2007) (0)
women's health study cognitive cohort Low dose aspirin and cognitive function in the (2007) (0)
Geographic Region, Racial/Ethnic Disparities, and Late-Life Depression: Results From a Large US Cohort of Older Adults. (2021) (0)
Pemafibrate improves triglyceride metabolism markers in a European population on background statin therapy (2020) (0)
Multiethnic Cohort of Nonsmoking Women Comparison of Lifestyle-Based and Traditional Cardiovascular Disease Prediction in a (2014) (0)
094: Framingham Risk Score Predicts Prevalent Chronic Kidney Disease in Women (2005) (0)
Abstract 10005: Sodium Intake and Risk of Cardiovascular Disease: A Pooled Analysis of Individual Data from Six Cohort Studies with Multiple 24-Hour Urine Collections (2021) (0)
Fruit and vegetable consumption does not protect against colon or rectal cancer (2001) (0)
Follow-Up of the Tohp Randomized Sodium Reduction Interventions for Subsequent Cardiovascular Disease and Mortality (2006) (0)
RISK FACTORS ASSOCIATED WITH INCIDENT PERSISTENT ATRIAL FIBRILLATION AT TIME OF DIAGNOSIS (2023) (0)
Cardiovascular Risk Evaluation Tools Specific to Population With Diabetes—Reply (2012) (0)
Abstract 16061: Lipoprotein(a) and Cardiovascular Risk Prediction in Women (2017) (0)
1102 Fish oil supplementation and pro-inflammatory and pro-resolving lipid mediators in patients with and without systemic lupus erythematosus (2021) (0)
Serum Vitamin D: Correlates of Baseline Concentration and Response to Supplementation in VITAL-DKD. (2021) (0)
Medical Decision Making and MDM Policy & Practice Reviewers, 2016 (2017) (0)
Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings From a Randomized Trial (2022) (0)
B-PO04-163 THE EFFECT OF MARINE OMEGA-3 FATTY ACID SUPPLEMENTATION ON ELECTROCARDIOGRAPHIC RISK PROFILES: RESULTS FROM THE VITAL RHYTHM STUDY (2021) (0)
A37 Accounting for missing data in clinical trials of blood pressure (BP) and hypertension (1996) (0)
Abstract P178: Vitamin D Biomarkers with Risk of Hypertension and Renin-Angiotensin System (2016) (0)
Book review (2004) (0)
Abstract 11875: Risk of Malignant Cancer Among Women With New-onset Atrial Fibrillation (2015) (0)
Abstract 13397: Determining the Optimal Cutpoint Value for the Diagnosis of Hypertriglyceridemia in the Nonfasting Population (2014) (0)
Rationale and design of an ancillary study evaluating the effects of the cocoa flavanol and/or multivitamin interventions on falls and physical performance outcomes in the COcoa Supplement and Multivitamin Outcomes Study (COSMOS). (2023) (0)
Su1037 Aspirin versus Screening for Colorectal Cancer Prevention: Comparative Effectiveness Network Meta-Analysis (2016) (0)
Commentary : In pursuit of the ‘ best ’ possible evidence in investigations of breast implants and connective tissue disease (2011) (0)
BREAST IMPLANTS AND CONNECTIVE-TISSUE DISEASE. AUTHORS' REPLY (1996) (0)
Response to Letter Regarding Article, “Birth Weight Is a Significant Risk Factor for Incident Atrial Fibrillation” (2011) (0)
Abstract P084: Racial Variation in Stroke Risk by Stroke Risk Factors (2017) (0)
Headache in a community population of elderly (1986) (0)
HYPERTRIGLYCERIDEMIA, INFLAMMATION, HYPERCHOLESTEROLEMIA, AND FUTURE CARDIOMETABOLIC DISEASE RISK: A DATA DRIVEN CLUSTER ANALYSIS IN THE WOMEN's HEALTH STUDY (2020) (0)
Abstract 140: Plasma Interleukin-6 Levels And Cardiovascular Events In The Cirt Trial: Consistent Associations For Incident Coronary, Cerebrovascular, And Peripheral Artery Disease (2022) (0)
hypertension prevention ( TOHP ) observational follow-up of the trials of on cardiovascular disease outcomes : Long term effects of dietary sodium reduction (2007) (0)
NT-PROBNP AND THE RISK OF INCIDENT DIABETES IN WOMEN (2011) (0)
Abstract 13007: LDL-Triglyceride Content, LDL-Cholesterol to LDL-Triglyceride Ratio,and Associations With Incident Cardiovascular Disease: Prospective Data From the Women’s Health Study (2019) (0)
Abstract 17400: Using Electronic Health Records for Predicting Hospitalization of COVID-19 Patients in Massachusetts (2020) (0)
Impact of Vitamin D3 Versus Placebo on Cardiac Structure and Function: A Randomized Clinical Trial (2022) (0)
Meta-analysis of LDL-C Lowering and Mortality. (2018) (0)
Abstract 14943: Comparison of Fasting and Nonfasting Lipoprotein Subfractions and Size in 13,460 Apparently Healthy Individuals (2017) (0)
Effects of Vitamin D3 Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL (2022) (0)
Biomarkers for Prediction of Cardiovascular Events. Authors' reply (2009) (0)
Cardiac Death Common Variants in Cardiac Ion Channel Genes Are Associated With Sudden (2010) (0)
Abstract 3124: The Magnitude of Reclassification Indices for Individual Predictors of Global Cardiovascular Risk (2008) (0)
Abstract 13797: The Lipophilic Index of Red Blood Cell Membranes and Risk of Sudden Cardiac Death in Women (2014) (0)
Prospective Evaluation of the Alcohol Dehydrogenase (cid:1) 1/ (cid:1) 2 Gene Polymorphism and Risk of Stroke (2004) (0)
Abstract P192: Metabolomic Profiles Associated with Coronary Heart Disease in Women (2016) (0)
Fish consumption, omega-3 fatty acids (n-3), and nmr lipoprotein subfractions in 26034 apparently healthy women (2015) (0)
Abstract 19867: Fasting Ghrelin, Body Mass Index and Risk of Incident Diabetes in Women (2010) (0)
Abstract 033: Directly Measured Triglyceride-Rich Lipoprotein Cholesterol and Small Dense LDL-Cholesterol Concentrations Associate With Incident Cardiovascular Disease: Prospective Data From the Women’s Health Study (2019) (0)
Special Report Screening for Sudden Cardiac Death in the Young Report from a National Heart, Lung, and Blood Institute Working Group Cost Estimates for a National Ecg Screening Program in the United States For (2011) (0)
Multi-Ancestral Analysis of Inflammation-Related Genetic Variants and C-Reactive Protein in the Population Architecture using Genomics and Epidemiology (PAGE) Study (2014) (0)
Abstract MP35: Physical Activity Before and After Cancer Diagnosis and Total and Cause-Specific Mortality (2018) (0)
Abstract 049: Derivation and Validation of a Lifestyle CVD Risk Score for the Prediction of CVD Among Middle-aged Women and Men (2013) (0)
Abstract 16471: Lipoprotein(a) Cholesterol and Cardiovascular Events in the VITamin D and OmegA 3 TriaL (Vital) (2020) (0)
Abstract 4202: Migraine is Associated with Increased Risk of Cardiovascular Disease in Men (2006) (0)
Abstract 12158: Impact of Modifiable Risk Factors on Circulating Concentrations of B-type Natriuretic Peptide and Cardiac Troponin T (2015) (0)
META-ANALYSIS OF THE ASSOCIATION BETWEEN A COMMON VARIANT IN THE BETA-2 ADRENERGIC RECEPTOR AND SUDDEN CARDIAC DEATH (2010) (0)
Response to “More on Migraine and Coronary Artery Disease” (2003) (0)
Medical Decision Making and MDM Policy & Practice Reviewers, 2018. (2019) (0)
Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk. Reply. (2022) (0)
Response to: Errors in application of the Kawasaki formula to estimate sodium intake, and false interpretation of data, misclassify the relationship of sodium intake with mortality. (2019) (0)
Fish oil supplementation in patients with and without systemic lupus erythematosus: targeting pro-inflammatory and pro-resolving lipid mediators. (2022) (0)
Vitamin D and Omega-3 Fatty Acids and Bone Health: Ancillary Studies in the VITAL Randomized Controlled Trial (2016) (0)
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events An 8-Year Follow-Up of 14 719 Initially Healthy American Women Clinical Investigation and Reports (2003) (0)
Combining Field and Laboratory Experiments in Order to Understand Interactions Between Flow, Sediment, Vegetation And Bank Erosion in Riparian Rehabilitation Works (2005) (0)
Abstract MP01: Physical Activity and Incident Cardiovascular Disease in Women: Is the Relation Influenced by Level of Global Cardiovascular Risk? (2015) (0)
Lack of association between genetic variation in 9 innate immunity genes and baseline CRP levels. (2006) (0)
Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial (2022) (0)
P-167 B vitamins and cognitive function among women at high risk of cardiovascular disease: A randomized trial (2007) (0)
Abstract 15512: Sodium Intake and All-Ccuse Mortality Over 20 Years of Follow-up (2015) (0)
Abstract 12536: A Sensitive Cardiac Troponin T Assay and the Risk of Incident Cardiovascular Disease in Women with and without Diabetes: The Women's Health Study (2010) (0)
Abstract TP433: Effect of Vitamin D and Marine Omega-3 Fatty Acid Supplements on Stroke Outcomes (2020) (0)
P1.03-066 Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer TNM Staging: Topic: Staging (2017) (0)
Abstract 1968: Common Variants in Cardiac Ion Channel Genes Are Associated With Sudden Cardiac Death (2009) (0)
Compliance in the physician's health study (1991) (0)
Efficacy of vitamin D3 supplementation on cancer mortality: Systematic review and individual patient data meta-analysis of randomised controlled trials (2023) (0)
Abstract 3503: Low Dose Aspirin and Incident Diabetes Mellitus in Apparently Healthy Middle-Aged American Women - the Women's Health Study (2007) (0)
Abstract 15959: N-6 Polyunsaturated Fatty Acids in RBC Membranes and Estimated Desaturase Activities and Risk of Sudden Cardiac Death (2015) (0)
Effect of Vitamin D 3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty An Ancillary Study of a Randomized Clinical Trial (2022) (0)
Dose-Response Models May Explain Age-Related Macular Degeneration and Vitamin Treatments-Reply. (2021) (0)
Abstract 19462: Improvement of 10-Year Cardiovascular Risk Prediction Using Hemoglobin A1c in Diabetic Women Compared to Classification of Diabetes as a Cardiovascular Risk Equivalent (2010) (0)
P-174 Type 2 diabetes and cognitive decline in a large sample of community-dwelling older men and women (2007) (0)
The Presence of Alzheimer's Disease in a Community Population-Reply (1990) (0)
Abstract 18361: Lipidomic Profiles are Associated With Incident Coronary Heart Disease in Women (2015) (0)
Abstract 11848: Biomarkers of Glucose-Insulin Homeostasis, Randomized Treatment With Omega-3 and Vitamin D Supplementation, and Incident Type 2 Diabetes: Prospective Analysis From the Vitamin D and Omega-3 Trial (VITAL) (2021) (0)
Abstract 3787: Nontraditional Risk Factors and Cardiovascular Disease Incidence in Type 2 Diabetes: Prospective Data from the Women's Health Study (2007) (0)
B-PO02-164 GENOME-WIDE POLYGENIC RISK SCORE PREDICTS SUDDEN ARRHYTHMIC DEATH IN PATIENTS WITH CORONARY ARTERY DISEASE (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nancy R. Cook?

Nancy R. Cook is affiliated with the following schools:

Nancy R. Cook's Academic­Influence.com Rankings

Nancy R. Cook's Degrees

Similar Degrees You Can Earn

Why Is Nancy R. Cook Influential?

Nancy R. Cook's Published Works

Published Works

What Schools Are Affiliated With Nancy R. Cook?

Nancy R. Cook's AcademicInfluence.com Rankings